An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice

NCT ID: NCT01893268

Last Updated: 2018-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

279 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-07-25

Study Completion Date

2018-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective, observational study will assess the effectiveness and safety of Avastin (bevacizumab) as 1st line therapy in elderly patients with advanced non-squamous non-small cell lung cancer in clinical practice. Therapy with Avastin and standard chemotherapy will be administered according to the treating physician. Data will be collected for approximately 4 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Squamous Non-Small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients, \>= 65 years of age
* Diagnosis of advanced non squamous Non-Small Cell Lung Carcinoma (nsNSCLC, stage IIIB or IV) for whom the physician has decided to initiate a treatment with Avastin combined with chemotherapy as 1st line therapy
* Having received oral and written information about the study, and having signed a written consent form

Exclusion Criteria

* Participation in a cancer clinical trial with an investigational medicinal product other than this study
* Patient previously treated with Avastin
* Patient under supervision or guardianship
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique Du Docteur Calabet; Cromg

Agen, , France

Site Status

Ch Du Pays D Aix; Pneumologie

Aix-en-Provence, , France

Site Status

Poly Parc Rambot La Provencale; Chimiotherapie Ambulatoire

Aix-en-Provence, , France

Site Status

Cabinet Medical

Amiens, , France

Site Status

Centre Hospitalier Uni Ire; Pneumology

Angers, , France

Site Status

Chic Cote Basque Bayonne; Pneumologie

Bayonne, , France

Site Status

HOPITAL JEAN MINJOZ; Oncologie

Besançon, , France

Site Status

CH Germon ET Gauthier; Pneumologie

Beuvry, , France

Site Status

Ch De Beziers; Pneumologie

Béziers, , France

Site Status

Hopital Avicenne; Cancerologie

Bobigny, , France

Site Status

Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie

Bordeaux, , France

Site Status

Centre Hospitalier Fleyriat; Oncologie/Hematologie

Bourg-en-Bresse, , France

Site Status

Ch De Fleyriat; Pneumologie 1

Bourg-en-Bresse, , France

Site Status

Hia Clermont Tonnerre; Pneumologie

Brest, , France

Site Status

Ch De Brive La Gaillarde; Radiotherapie Oncologie

Brive-la-Gaillarde, , France

Site Status

Hopital Louis Pradel; Pneumologie

Bron, , France

Site Status

Hopital Pierre Nouveau; Pneumologie

Cannes, , France

Site Status

Ch Antoine Gayraud; Oncologie

Carcassonne, , France

Site Status

Clinique Du Parc; Hematologie

Castelnau Lez, , France

Site Status

Ctre Medical Nicolas de Pontoux

Chalon-sur-Saône, , France

Site Status

Ch De Chauny; Pneumologie

Chauny, , France

Site Status

CH Du Cotentin Site De Cherbourg; Hopital De Jour

Cherbourg Octeville, , France

Site Status

Hopital Gabriel Montpied; Service de Pneumologie

Clermont-Ferrand, , France

Site Status

Centre Jean Perrin; Hopital De Semaine

Clermont-Ferrand, , France

Site Status

Hopital Louis Pasteur; Pneumologie Tabacologie

Colmar, , France

Site Status

Centre Hospitalier Alpes Leman CHAL;Pneumologie

Contamine-sur-Arve, , France

Site Status

Clinique Des Cedres; Pneumologie

Cornebarrieu, , France

Site Status

Centre Hospitalier Intercommunal; Service de Pneumologie

Créteil, , France

Site Status

Chu Site Du Bocage;Pneumologie

Dijon, , France

Site Status

Ch De La Dracenie; Pneumologie

Draguignan, , France

Site Status

Centre D Oncologie Dunkerquois

Dunkirk, , France

Site Status

Chi Emile Durkheim Site Epinal; Pneumologie

Épinal, , France

Site Status

Chi Alpes Du Sud Site De Gap; Pneumologie

Gap, , France

Site Status

Hopital Nord Ouest;Unite 2c

Gleizé, , France

Site Status

CH Emmanuel Rain; Oncologie

Gonesse, , France

Site Status

Hopital Prive De Chantilly; Medecine

Gouvieux Chantilly, , France

Site Status

Hopital D Hayange;Medecine A Et P

Hyères, , France

Site Status

Centre Oscar Lambret; Chir Cancerologie General

Lille, , France

Site Status

Hopital Saint Vincent; Consult et Explorations

Lille, , France

Site Status

Hopital Calmette; Pneumologie Oncologie Ouest

Lille, , France

Site Status

Clinique Chenieux; Oncology

Limoges, , France

Site Status

Hopital Du Cluzeau; Service de Pathologie Respiratoire

Limoges, , France

Site Status

Hopital Dupuytren; Pneumologie

Limoges, , France

Site Status

Centre Hospitalier Général; Pneumologie

Longjumeau, , France

Site Status

Ch Bretagne Sud Site Scorff; Oncologie Medicale

Lorient, , France

Site Status

Centre Medical Parot

Lyon, , France

Site Status

Centre Hospitalier François Quesnay; Pneumologie-Neurologie

Mantes-la-Jolie, , France

Site Status

Hôpital Saint Joseph; Oncologie Medicale

Marseille, , France

Site Status

Centre Hospitalier; Pneumologie

Metz-Tessy, , France

Site Status

Hopital Layne; Medecine Ambulatoire

Mont-de-Marsan, , France

Site Status

Ch De Montauban; Pneumologie

Montauban, , France

Site Status

Hopital Emile Muller;Pneumologie

Mulhouse, , France

Site Status

Cabinet Medical

Nancy, , France

Site Status

Polyclinique Gentilly; CHIMIOTHERAPIE AMBULATOIRE

Nancy, , France

Site Status

Hopital Caremeau; Pneumologie

Nîmes, , France

Site Status

Clinique sainte marie; chimiotherapie ambulatoire

Osny, , France

Site Status

Hopital Cochin; Unite Fonctionnelle D Oncologie

Paris, , France

Site Status

Hopital Saint Louis; Oncologie Medicale

Paris, , France

Site Status

Hopital Europeen Georges Pompidou; Service D'Oncologie Medicale

Paris, , France

Site Status

Centre Catalan D' Oncologie

Perpignan, , France

Site Status

Centre Hospitalier Lyon Sud; Pneumologie

Pierre-Bénite, , France

Site Status

CH Rene Dubos; Oncologie

Pontoise, , France

Site Status

Hopital Laennec; Service de Pneumologie

Quimper, , France

Site Status

Ch De Rambouillet; Pneumologie Cardiologie

Rambouillet, , France

Site Status

Cabinet

Reims, , France

Site Status

Hopital de Pontchaillou; Service de Pneumologie

Rennes, , France

Site Status

Clinique Saint Hilaire; Sce Chimiotherapie

Rouen, , France

Site Status

Centre Cardiologique Du Nord; Pneumologie

Saint-Denis, , France

Site Status

Clinique de L'Union; Oncologie

Saint-Jean, , France

Site Status

Cabinet Medical

Saint-Laurent-du-Var, , France

Site Status

Hopital Nord; Service de Pneumologie

Saint-Priest-en-Jarez, , France

Site Status

Ch De Saint Quentin; Medecine B14

Saint-Quentin, , France

Site Status

Ch De Saintonge; Unite 2 Pneumologie

Saintes, , France

Site Status

Centre Medical National Mgen; Pneumologie

Ste Feyre, , France

Site Status

Centre Paul Strauss; Oncologie Medicale

Strasbourg, , France

Site Status

Hopital Bel Air; Pneumologie Allergologie

Thionville, , France

Site Status

Hopitaux Du Leman Site Thonon; Pneumologie

Thonon-les-Bains, , France

Site Status

Hia Sainte Anne; Pneumologie

Toulon, , France

Site Status

Hopital Sainte Musse; Pneumologie

Toulon, , France

Site Status

Clinique Pasteur; Pneumologie

Toulouse, , France

Site Status

Groupe Oncorad Garonne; Unite Onco Hematologie

Toulouse, , France

Site Status

Cabinet Medical

Tours, , France

Site Status

Hopital Des Hauts Clos; Pneumologie

Troyes, , France

Site Status

Ch De Valence; Medecine 7

Valence, , France

Site Status

Centre Alexis Vautrin; Oncologie Medicale

Vandœuvre-lès-Nancy, , France

Site Status

Hopital Robert Schuman; Pneumologie

Vantoux, , France

Site Status

Hopital Saint Nicolas; Pneumologie

Verdun, , France

Site Status

Gh Mutualiste Les Portes Du Sud; Pneumologie

Vénissieux, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ML28621

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.